Is the Two-minute Step Test an Alternative to the Six-minute Walk Test in Pulmonary Hypertension?
1 other identifier
observational
35
1 country
1
Brief Summary
The aim of this observational study is to evaluate the validity of the 2-minute step test in assessing functional capacity in pulmonary hypertension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2025
CompletedFirst Submitted
Initial submission to the registry
September 17, 2025
CompletedFirst Posted
Study publicly available on registry
September 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 25, 2026
ExpectedMay 7, 2026
May 1, 2026
9 months
September 17, 2025
May 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
2 Minute Step Test
The 2-minute step test (2MST) is a test used to assess functional capacity. The maximum number of knee lifts the individual can perform within 2 minutes will be counted, with the minimum height occurring at the midpoint between the patella and the anterior superior iliac spine (during steady walking, without changing position). The test will be performed with a mobile ergospirometer (K5, Cosmed, Italy). Oxygen consumption, task-based heart rate, and ventilation obtained during the 2MST will be recorded. In addition, the Borg dyspnea and fatigue scale will also be included in the assessment.
2 minutes
Secondary Outcomes (2)
Functional capacity
6 minutes
mMRC Dyspnea Scale
5 minutes
Interventions
The 2-Minute Step Test (2MST) is a simple, validated field test used to assess aerobic endurance and functional fitness, especially in older adults or people with chronic conditions (e.g., cardiopulmonary disease, neurological disorders).
Eligibility Criteria
Patients being diagnosed with pulmonary hypertension (PH)
You may qualify if:
- Being diagnosed with pulmonary hypertension (PH)
- Being 18 years of age or older
- Agreeing to participate in the study
You may not qualify if:
- Acute decompensated heart failure
- Orthopedic or neurological disorders that prevent the test from being performed
- Patients who have difficulty understanding the instructions given
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul University - Cerrahpasa
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Physiotherapist, PhD
Study Record Dates
First Submitted
September 17, 2025
First Posted
September 25, 2025
Study Start
September 15, 2025
Primary Completion
June 15, 2026
Study Completion (Estimated)
June 25, 2026
Last Updated
May 7, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
The sharing of this information is restricted by the ethics committee and informed consent form.